Trials / Completed
CompletedNCT00903240
Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer
Phase 3 Study of Bladder Cancer Recurrence Surveillance
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Predictive Biosciences · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to detect recurrent bladder cancer using a combination of protein and DNA biomarkers in urine
Conditions
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-04-01
- Completion
- 2010-10-01
- First posted
- 2009-05-18
- Last updated
- 2011-06-08
Locations
20 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00903240. Inclusion in this directory is not an endorsement.